Transplacental Pharmacokinetics of the Antituberculosis Drugs

Overview

Journal Clin Pharmacokinet

Specialty Pharmacology

Date 1987 Aug 1

PMID 3304771

Citations 2

Authors

M R Holdiness

Affiliations

Soon will be listed here.

Citing Articles

Isoniazid metabolism and hepatotoxicity.

Wang P, Pradhan K, Zhong X, Ma X Acta Pharm Sin B. 2016; 6(5):384-392.

PMID: 27709007 PMC: 5045547. DOI: 10.1016/j.apsb.2016.07.014.

Clinical pharmacokinetics of clofazimine. A review.

Holdiness M Clin Pharmacokinet. 1989; 16(2):74-85.

PMID: 2656045 DOI: 10.2165/00003088-198916020-00002.

References

Holdiness M . Teratology of the antituberculosis drugs. Early Hum Dev. 1987; 15(2):61-74. DOI: 10.1016/0378-3782(87)90039-9. View

Snider Jr D, Layde P, Johnson M, Lyle M . Treatment of tuberculosis during pregnancy. Am Rev Respir Dis. 1980; 122(1):65-79. DOI: 10.1164/arrd.1980.122.1.65. View

Cohen S, Baumgartner R, Steinberg M, Weber W . Changes in the physicochemical characteristics of rabbit liver N-acetyltransferase during post-natal development. Biochim Biophys Acta. 1973; 304(2):473-81. DOI: 10.1016/0304-4165(73)90267-5. View

Baron H, EPSTEIN I, Mulinos M, Nair K . Absorption, distribution, and excretion of cycloserine in man. Antibiot Annu. 1955; 3:136-40. View

WOLTZ J, Wiley M . Transmission of streptomycin from maternal blood to the fetal circulation and the amniotic fluid. Proc Soc Exp Biol Med. 2010; 60:106. DOI: 10.3181/00379727-60-15106. View

Cohen S, Weber W . Newborn infants of tuberculous mothers, further comment. Pediatrics. 1969; 43(2):303-4. View

GRASSET E, DE WATTEVILLE H, DOSSENA P . [Streptomycin permeation of the placenta in pregnancy]. Presse Med (1893). 1951; 59(61):1265-7. View

Weber W, Hein D . Clinical pharmacokinetics of isoniazid. Clin Pharmacokinet. 1979; 4(6):401-22. DOI: 10.2165/00003088-197904060-00001. View

Holdiness M . Chromatographic analysis of antituberculosis drugs in biological samples. J Chromatogr. 1985; 340:321-59. DOI: 10.1016/0378-4347(85)80201-2. View

10.

GOOD R, Johnson G . The placental transfer of kanamycin during late pregnancy. Obstet Gynecol. 1971; 38(1):60-2. View

11.

Holdiness M . Neurological manifestations and toxicities of the antituberculosis drugs. A review. Med Toxicol. 1987; 2(1):33-51. DOI: 10.1007/BF03259859. View

12.

BROMBERG Y, SALZBERGER M, BRUDERMAN I . Placental transmission of isonicotinic acid hydrazide. Gynaecologia. 1955; 140(3):141-4. DOI: 10.1159/000308070. View

13.

Kenny M, STRATES B . Metabolism and pharmacokinetics of the antibiotic rifampin. Drug Metab Rev. 1981; 12(1):159-218. DOI: 10.3109/03602538109011084. View

14.

ROCKER I . Rifampicin in early pregnancy. Lancet. 1977; 2(8027):48. DOI: 10.1016/s0140-6736(77)90056-3. View

15.

Snider D . Pregnancy and tuberculosis. Chest. 1984; 86(3 Suppl):10S-13S. DOI: 10.1378/chest.86.3.10s. View

16.

Shneerson J, Francis R . Ethambutol in pregnancy--foetal exposure. Tubercle. 1979; 60(3):167-9. DOI: 10.1016/0041-3879(79)90018-7. View

17.

Reidenberg M, SHEAR L, Cohen R . Elimination of isoniazid in patients with impaired renal function. Am Rev Respir Dis. 1973; 108(6):1426-8. DOI: 10.1164/arrd.1973.108.6.1426. View

18.

Miceli J, Olson W, Cohen S . Elimination kinetics of isoniazid in the newborn infant. Dev Pharmacol Ther. 1981; 2(4):235-9. View

19.

Holdiness M . Cerebrospinal fluid pharmacokinetics of the antituberculosis drugs. Clin Pharmacokinet. 1985; 10(6):532-4. DOI: 10.2165/00003088-198510060-00006. View

20.

Holdiness M . Clinical pharmacokinetics of the antituberculosis drugs. Clin Pharmacokinet. 1984; 9(6):511-44. DOI: 10.2165/00003088-198409060-00003. View